Our data demonstrated that OEA was able to effectively prevent plaque formation through anti-inflammatory action and modulate serum LDL and HDL contents in atherosclerosis animals, indicating the atheroprotective roles of PPAR-α and its agonist OEA. The gene discussed is PPARA; the disease is atherosclerosis.